Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study

BACKGROUND: Our previous work has demonstrated the benefits of transcutaneous immunization in targeting Langerhans cells and preferentially inducing CD8 T-cell responses. METHODS: In this randomized phase Ib clinical trial including 20 HIV uninfected volunteers, we compared the safety and immunogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez, Jorge, Gonçalves, Elena, Llano, Anuska, Gonzáles, Pedro, Fernández-Maldonado, María, Vogt, Annika, Soria, Angele, Perez, Susana, Cedeño, Samandhy, Fernández, Marco Antonio, Nourikyan, Julien, de Bernard, Simon, Ganoza, Carmela, Pedruzzi, Eric, Bonduelle, Olivia, Mothe, Beatriz, Gòmez, Carmen E., Esteban, Mariano, Garcia, Felipe, Lama, Javier R., Brander, Christian, Combadiere, Behazine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683801/
https://www.ncbi.nlm.nih.gov/pubmed/33244316
http://dx.doi.org/10.3389/fimmu.2020.586124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683801/
https://www.ncbi.nlm.nih.gov/pubmed/33244316
http://dx.doi.org/10.3389/fimmu.2020.586124

Ejemplares similares